We speculated that elevated circulating CILP-2 levels might be due to the impairment of CILP-2 signaling in target tissues and/or the dysregulation of CILP-2, which is caused by changes in biosynthesis and release or in response to hyperglycemia, hyperinsulinemia or adipokines in IR state. Here, CILP2 is linked to Hyperglycemia.